GORDON, K. B.; LANGLEY, R. G.; WARREN, R. B.; OKUBO, Y.; ROSMARIN, D.; LEBWOHL, M.; PETERSON, L.; MADDEN, C.; DE CUYPER, D.; GOMEZ, N. N.; THAÇI, D. Bimekizumab safety in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in phase 2 and 3 clinical trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s66, 2022. DOI: 10.25251/skin.6.supp.66. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1821. Acesso em: 3 jul. 2024.